Braf V600e Mutation and Amphiregulin (Ar) Immunohistochemical Expression in the Prediction of Benefit From Cetuximab Plus Irinotecan in Kras Wildtype Metastatic Colorectal Cancer (Mcrc) Patients
Journal article published in 2009 by
C. Cremolini,
F. Loupakis,
G. Perrone,
A. Ruzzo,
E. Rulli,
D. Garavaglia,
K. Bencardino,
L. Fornaro,
B. Vincenzi,
I. Stasi,
G. Masi,
D. Santini,
E. Vasile,
L. Salvatore 
,
G. G. Baldi
and other authors.
,
G. G. Baldi
and other authors.
